1Department of Botany, RKDF University, Ranchi, Jharkhand - 834004, India.
2Department of Zoology, RKDF University, Ranchi, Jharkhand - 834004, India.
3Department of Chemistry, JIS College of Engineering, Kalyani, West Bengal 741235, India.
4Department of Chemistry, Darjeeling Government College, Darjeeling, West Bengal, 734101, India.
5Department of Botany, Balurghat College, Balurghat, West Bengal - 733101, India.
Medicinal plants, owing the richest source of drugs for the traditional medicine, food supplements, modern as well as folk medicines, fragrances, significant efforts have been paid for driving the quest for potential bioactive chemicals derived from them. Plant extracts have been used to cure a variety of illnesses for a very long time in many civilizations. In many cases, efforts are made to properly validate and comprehend the usefulness of these folk treatments without analyzing the bioactive chemicals in plants i.e. the mature leaves of Sanchezia oblonga Ruiz & Pav. is crushed into little pieces and applied to the body to treat cyanosis, tendonitis, and backaches. Herein leaf extracts of Sanchezia oblonga Ruiz & Pav. were used to test for the presence of phytochemicals and investigate the plant's pharmacological properties. The isolation of phytochemicals using TLC, GC-MS, analysis and UV visible spectroscopy reveals the existence of nine bioactive compounds. Additionally, in-silico and DFT analysis clearly indicates that Stearic Acid possesses highest activity affinity for binding and pharmacological potential against different target proteins among the isolated phytochemicals.
A medicinal plant is any plant that contains compounds that can be utilized for therapeutic purposes or that serves as a precursor for the creation of important pharmaceuticals. Normally, scientific researchers are responsible of assessing the benefit of plant families. Local people, on the other hand, are best qualified to determine the usefulness of specific plant species for a given application because they can draw on empirical knowledge gathered over a period of time[1]. Over millions of years, they have changed and adapted to fend off bacteria, insects, fungi, and the environment to create distinctive secondary metabolites with a variety of structural characteristics. Their ethno pharmacological properties have been used as a primary source of medicines for early drug discovery [2]. According to the World Health Organization (WHO), 80% of people still rely on plant based traditional medicines for primary health care (Farnsworth et al., 1985) and 80% of the plant derived drugs were related to their original ethno pharmacological purpose [3]. People have looked for natural remedies for their illnesses since ancient times. As is the case with animals, the first uses of medicinal plants were instinctual. Natural products have been used since ancient times and in folklore for the treatment of many diseases and illnesses[4]. They have been the source of most of the active ingredients of medicines. This is widely accepted to be true when applied to drug discovery in ‘olden times’ before the advent of high through screening and the post genomicera [5]. In truth, everything depended on practice because there wasn't enough information available at the time about the causes of the ailments or the best plant to use as a preventive medicine. As specific medicinal plants for treating particular ailments came to light over antiquity, the empirical base for their use grew and they started to be used as explanatory evidence. Up until the invention of medical science in the 16th century, prevention and therapy were provided by plants (Sofowora 2013)[6]. Since 5000 BC, medicinal herbs have been used in India as part of the Ayurvedic medical system. For the purpose of preventing and treating disease, this approach comprises dietary guidelines and herbal medicines that are tailored to the body, mind, and spirit [7]. According to reports, herbal medicines and their active ingredients can effectively heal human diseases and disorders while also having positive impacts on long term fitness.[3]. Since the beginning of time, people have researched using herbal remedies to treat a variety of illnesses and relieve pain. In addition to the aforementioned, the usage of medicinal plants dates back 60,000 years, when a Sumerian clay slab, a sort of equipment, was unearthed and used to verify the use of medicinal plants in the production of medications. Today, more than 50% of medications are natural and have some connection to plants in their origin.[3] Currently, both developed and developing nations frequently employ herbal medications for healthcare. Herbal medications are regarded as mixes of chemical substances produced by plants, and their effectiveness is constrained due to poor oral absorption. In the current situation, it becomes vital to standardise herbal goods and evaluate medicine quality in order to determine the quantity of their active constituents. The first record of using medicinal plants to make medications dates back to roughly 5000 years ago and was discovered on a Sumerian slab of clay from Nagpur. It contains 12 drug synthesis formulas that allude to more than 250 different plants, some of which contain alkaloids including mandrake, poppy, and henbane [3] . Proof from the Old Testament and the most sacred Jewish scripture called the Talmud showed that aromatic herbs like myrtle and incense were used during numerous rites following a treatment.[3] Many of the drugs that are currently on the market have either been directly or indirectly produced from plants, which have historically been an excellent source of pharmaceuticals. According to ethnobotanical data, 800 plants may have anti-diabetic properties (Alarcon-Aguilara et al., 1998)[8]. When tested using currently available experimental procedures, a number of these herbs have demonstrated anti-diabetic action. According to Bailey and Day (1989), Ivorra et al. (1988), Marles and Farnsworth (1995), a variety of active principles derived from plants that represent a variety of chemical compounds have shown activity commensurate with their potential application for the therapeutic use of Non-Insulin-Dependent-Diabetes. [9]. They play a key role in offering basic healthcare to people who live in rural areas. They are also used as essential components for the production of both conventional and modern medications as well as therapeutic agents. Tropical rainforests in central and south America are home to the perennial evergreen shrub Sanchezia nobilis (Acanthaceae)[10]. Plants in the Sanchezia genus can be utilised as anti-tuberculosis, anti-tumor, anticonvulsants, cough sedatives, and expectorants in traditional medicine [11].The world's greatest diversity of plant species can be found in tropical regions, some of which may have therapeutic benefits. During the course of this investigation, Sanchezia nobilis, a tropical plant, was examined for its leaves. The lowland regions of tropical Central and South America are home to members of this genus, which are shrubs, small trees, and occasionally plants. The three species S. nobilis, S. parvibracteata, and S. speciosa are examples of well-known species [12]. Some species have become recognised for their therapeutic properties and are frequently utilised, but it is unknown whether the majority of plants in tropical forests contain active ingredients [13]. As a result, comprehensive scientific screening is needed to assess these plants. Therefore, the goal of this research effort was to look for bioactive substances and assess the pharmacological effects of this plant's leaves. According to studies, these substances have anti-inflammatory, anti-bacterial, anti-fungal, anti-cancer, and antioxidant activities. There haven't been many investigations into Sanchezia speciosa's pharmacological properties and chemical composition. Therefore, there is no exhaustive identification of the basic chemical constituents and comprehensive quality control of this genus. S. speciosa contains cardiac and flavonoid glycosides and their extracts exhibit antioxidant and anti-inflammatory activities [14]. Extracts of the same species exerted cytotoxicity in human epithelial cervical cancer cell lines[14]. Sanchezia oblonga Ruiz & Pav. (syn. Sanchezia nobilis Hook. f.) is a perennial evergreen shrub from the rainforests of Central and South America[15]. An previous study discovered that S. nobilis extracts include syringin, flavone glycosides, cinnamyl and benzyl alcohol glycosides, and neolignan glucoside in addition to the matsutake alcohol glycosides. When necessary, the bioactive ingredient is then extracted, fractionated, and isolated. In addition, it comprises determination of quantity and quality of bioactive compounds. Efficacy and ease of administration are among the reasons that plants are becoming increasingly popular as source of medicine, especially since they are natural, are available in local communities, and are cheaper to buy. Furthermore, herbal medicine may be a substitute to conventional medicine in cases where a drug’s side effects are severe and drug resistance exists. When extracting medicinal plants, active substances such alkaloids, flavonoids, terpenes, saponins, steroids, and glycosides are separated from inert or inactive material using a suitable solvent and accepted extraction techniques. Plant products with high levels of phenolic and flavonoid chemicals have been shown to have antioxidant characteristics and are therefore utilised to treat age-related illnesses like Alzheimer's disease, Parkinsonism, anxiety, and depression[16]. The process of obtaining medicinal plants was carried out in a variety of ways such as maceration, infusion, decoction, percolation, digestion and Soxhlet extraction, superficial extraction, ultrasound-assisted, and microwave-assisted extraction[17]. In addition, thin-layer chromatography (TLC), high-performance liquid chromatography (HPLC), paper chromatography (PC), and gas chromatography (GC) were used in purification and separation of the secondary metabolites. When choosing an extraction technique, solvent to be employed, solvent pH, temperature, and solvent to sample ratio, it is crucial to take the nature of the plant material into account. It also relies on how the finished products are going to be used. The objective of this study was to evaluate various extraction solvents, procedures, fractionation, and purification techniques as well as phytochemical screening and identification of bioactive chemicals in Sanchezia oblongamedicinal plants.
Figure 1: Plant taxonomy and different parts of Sanchezia oblongamedicinal plants
Taxonomy and nomenclature
Sanchezia is a genus of the family Acanthaceae and tribe is Ruellieae was first briefly described by Ruiz and Pavon in 1974 and named by Jose Sanchez. The Plant is cultivated in India and mostly found in Western Ghat & Eastern GhatRoots and Leaves are the most important parts of the plant as shown in Table 1.The taxonomic classification of plants at the family stage is crucial in figuring out which plant species are valuable to the local population. According to Phillips and Gentry [18], certain plant families are unquestionably more helpful than others in particular use categories.According to Scotland and Vollesen [19], the family Acanthaceae has roughly 221 genera and 4000 species that are found widely throughout the Old and New World Tropics. An exceptional variety of taxa, morphological and ecological features, and geographical distribution distinguish the Acanthaceae as a global group of flowering plants. More than 93% of the Acanthaceae species on Madagascar are considered endemic, making it the island with the highest degree of endemism [20]. Furthermore, Acanthaceae boast a remarkably rich fossil record as well as marked taxonomic diversity [21]. Most species of Acanthaceae live in small populations, especially in tropical ecosystems that exhibit high alpha diversity. Tropical botanists have struggled with this for a long time as we attempt to understand the evolution of species in these regions. The genus Sanchezia is included in the subfamily Ruellieae. This genus is native to the New World and comprises 59 species which are diverse morphologically, ecologically, and geographically [22]. Sanchezia species are widely commercialized as ornamentals are often planted as street shrubs or living fences (Scotland and Vollesen, 2000).Sanchezia oblonga Ruiz & Pav. (Acanthaceae) belong to the family of neotropical herbs and shrubs. Sanchezia oblonga is a small, semi-woody erect evergreen shrub growing 1.3 to 2.4 meters. Stems are bright green to purple. Leaves are large, up to 26 centimeters in length, opposite, lanceolate. Green blade with clearly visible veins of white or yellow. Flowers are yellow, tubular, with red bracts, about 5 centimeters long, and borne in terminal spikes of 6 to 10 as shown in Figure 1. Fruits are oblong capsules with 6 to 8 circular, compressed seeds. Several species of Sanchezia, such as S. parvibracteata, S. nobilis and S. speciosa, are cultivated as ornamentals in tropical areas and botanical gardens due to their colorful leaves and conspicuous bright and colorful bracts and flowers. Recently, this genus was revised by Leonard and Smith (1964); among 58 species, over half were newly described [23].Sanchezia is named for José Sánchez, a nineteenth-century professor of botany at Cádiz, Spain (Clay et al., 1987).They reported Species of ot this genus are S. lampra, S. ovata Ruiz & Pav., S. parvibracteata , S. parviflora, S. peruviana, S. putumayensis , S. sericea, S. speciosa, S. nobilis Hook.f. (Wiersema and León, 2013)[24], S. oblonga (wikispecies: Sanchezia oblonga).
Table 1: Distribution of plants in different regions of Indian
Continent/Country/Region |
Distribution |
Origin |
Reference |
Notes |
Andhra Pradesh |
Present |
Introduced |
India Biodiversity (2014) |
Cultivated |
Karnataka |
Present |
Introduced |
India Biodiversity (2014) |
Cultivated |
Tamil Nadu |
Present |
Introduced |
India Biodiversity (2014) |
Cultivated |
West Bengal |
Present |
Introduced |
India Biodiversity (2014) |
Cultivated |
After drying, the plant materials were ground well into fine powder. The fresh leaves along with their petioles (1 kg) of the above plant were dried at 60 °C in a hot-air oven for 3–4 days. The dried leaves (300 g) were crushed into fine powder using mixer grinder.
The 100 g of powder drug was extracted in a Soxhlet extractor in 500 mL of 95% methanol and double distilled water separately at room temperature (30 °C) for 72–96 h. Then the extracts were filtered using Whatman No.1 filter paper. The pigments of the filtrate were removed by running in activated charcoal column. The pigment free samples were concentrated using rotary vacuum evaporator (Superfit Rotary Vacuum Evaporator, R-150, Mumbai, India) at 40 °C. From the final dry weight of 300 g of plant sample, 30 g of active methanol extract of Sanchezia oblonga was recovered. The active extracts of planti.e methanol extractswas kept aseptically at 4°C until use.
Solvent extraction and pigment free :The 100 g of powder drug was extracted in a Soxhlet extractor in 500 mL of 95% analytical graded methanol at room temperature (30 °C) for 72–96 h. Then the extracts were filtered using Whatman No.1 filter paper. The pigments of the filtrate were removed by running in activated charcoal column.
Extract was to begin with, checked by TLC was performed after separation of major purified compound using MERCK TLC silica gel 60 F254 aluminium sheet. TLC with the separated purified compound used as stationery phase was carried out eluted by a standardized mixture of n-hexane and ethyl acetate in a ratio of 1:1 as mobile phase and visualized under 254 nm UV light. The Rf value was determined by calculating the ratio of the distance run by stationary phase to the distance run by mobile phase. The above prepared plant extracts were applied on precoated TLC plates by using capillary tubes and developed in a TLC chamber using suitable mobile phase. The developed TLC plates were air dried and observed under ultra violet light UV at both 254 nm and 366 nm. They were later sprayed with different spraying reagents and some were placed in hot air oven for 1 min for the development of color in separated bands. The movement of the analyze was expressed by its retention factor (Rf). Values were calculated for different sample.
Distance travel by solute
Rf = --------------------------------(Where Rf-Retention factor)
Distance travel by solvent
After drying the plates, they were exposed to Iodine vapours by placing in a chamber that was saturated with iodine vapours and also exposed to different spraying reagents. All plates were visualized directly after drying and with the help of UV at 254 nm and 366 nm in UV TLC viewer. The Rf value of the different pots that were observed was calculated.
To account the active photochemical in the fraction active fraction, gas chromatography-mass spectrometry (GC–MS) of the methanol fraction was carried out in a GC–MS instrument (Instrument No: GC-240 Ion Trap MS, Model:7890B, Agilent Technologies, USA) armored with a capillary column VF-5MS (ID-0.25MM, Film-0.25 µm, Length 31.98 min, Max temp. 325 °C).
Assessment of antibacterial activity of crude sample against Gram negative bacteria (E. coli) was measured by the agar well diffusion method. 5 mm wells were cut in each fresh inoculated bacterial plates and 10 µl of different concentration of the test sample was loaded into the 5 mm diameter well seeded with test bacteria and incubated for 24 h. at 37 °C. The potency was measured by zone diameter of growth inhibition of crude extracts.
In this study, all simulations were conducted using density functional theory (DFT) within the Gaussian 16 software package[25]. The ground-state geometries of all the phytochemicals were optimized at the B3LYP/6-31+G(d) level of theory[25]. To ensure that the optimized geometries correspond to true minima on the potential energy surfaces, a vibrational frequency analysis was performed at the same theoretical level, confirming the absence of imaginary frequencies. Optimized geometries are plotted using Gausview 6 program package[26].
Molecular Docking of the extracted compounds has been carried out by Autodock Vina programm package[27, 28]. The “sdf” files (3D-conformer) molecular structures of the nine extracted compounds are downloaded from PubChem (https://pubchem.ncbi.nlm.nih. gov/) and was converted to respective pdb files[29].
The crystal structure of two SARS-CoV-2 proteins (PDB ID:6LU7 and PDB ID:6w9c ) and two Ebola virus proteins ( PDB ID:1eS6 PDB ID: 4z9p), were retrieved from Protein Data bank (www.rcsb.org)[30]. All the structures of proteins were cleaned by removing hetero-atoms and water molecules using UCSF Chimera and site dependent run were carried outto evaluate the best binding sites of the extracted nine phytochemicals. To elucidate the binding site identification along with structural features of protein-drug com posite UCSF Chimera and Discovery Studio Visualizer have been used[31].
Phytochemical tests for bioactive constituents such as glycosides, saponins, anthraquinone derivatives, flavonoids, sterols, tannins, alkaloids, triterpenoids, phenols and leucoanthocyanidins were carried out on portion of residual material using standard phytochemical procedures as shown in the Table 2. The positive tests of these observations clearly indicates that Sanchezia oblonga is a source of phytochemicals like Tannins, Alkaloids, steroids, Flavonoids natural products.
Table 2: Phytochemical testsof the active constituents in Sanchezia oblonga extract
Experiments |
Observation |
Bioactive Compounds Present |
Plant material+ FeCl3+ distilled Water |
Blue-black precipitation |
Presence of Tannins |
Plant material + Methanol + HCl + Dragendorff solution |
Brownish-red precipitation |
Presence of Alkaloids |
Plant material + Water+ filtration |
Shaken vigorously for 2 minutes and stable foam formed |
Presence of Saponins |
Plant material + Chloroform + Acetic anhydride (1:1) |
Formation of blue-green ring |
Presence of Steroids |
Plant material + dil. NH3 + Conc. H2SO4 |
Yellow colour formed |
Presence of Flavonoids |
Plant material + 10% NH3 + CHCl3 |
Rose-pink colour formed |
Presence of Anthraquinone |
Figure 2. Microchemical colour reaction test of Sanchezia oblonga extractA: Ethanolic extract of the leaf powder; B- Methanolic extract of the leaf powder; C: n-Hexen extract of the leaf powder; D: Water extract of the leaf powder; E: Glycerol extract of the leaf powder.
Chromatographic separation of the constituent phytochemicals of theSanchezia oblonga extract by TLC revealed three distinct spots with Rf values of 0.29 (C2), 0.78 (C3) and 0.87 (C4), as shown in the Figure 3 . These different sub-fractions of from TLC scraped is collected separately and allowed for bioassay. Among the sub-fraction of TLC plate 0.78 (C3) was the potentially active.
Figure 3 : Thin layer chromatography analysis of Sanchezia oblonga extract
In order to explore the presence of the phytochemicals derived fromSanchezia oblonga the plant extract we have used Gas Chromatography Mass Spectrometryanalysis. GC-MS analysis showed there are nine major compounds are present in the methanolic extract. Table 3 illustrated the names, molecular mormula, molecular weight along with molecular structure of these major nine compounds.
Table3: GC-MS profiling of the active phytochemicals of Sanchezia oblonga:
Sl. No. |
Chemical name |
Molecular formula |
Molecular weight (g/mol) |
Molecular structure |
1 |
5methyl4hepten3one |
C8H14O
|
126.20 g/mol |
|
2 |
Campesterol
|
C28H48O
|
400.7 g/mol |
|
3 |
Linoleic acid |
C18H32O2
|
280.45 (g/mol) |
|
4 |
Oleanolic Acid |
C30H48O3, |
456.7 g/mol |
|
5 |
Palmitic Acid |
C16H32O2, |
256.43 (g/mol) |
|
6 |
Phytol |
C20H40O
|
296.5 g/mol |
|
7 |
Squalene |
C30H50 |
410.7 g/mol |
|
8 |
Stearic Acid |
C18H36O2
|
284.5 g/mol |
|
9 |
Stigmasterol |
C29H48O |
412.7 g/mol |
|
Table 4 : Binding affinities of the the phytochemicals derived from Sanchezia oblonga againts Covid protein and Ebola Virus proteins
Drugs |
6lu7 Covid protein |
6w9c Covid protein |
1eS6 Ebola Virus |
4z9p Ebola Virus |
5_methyl_4_hepten_3_one |
-3.8 |
-4.3 |
-4.2 |
-4.0 |
Campesterol |
-6.7 |
-6.4 |
-6.6 |
-6.2 |
Linoleic acid |
-4.6 |
-4.4 |
-4.4 |
-3.9 |
Oleanolic Acid |
-7.4 |
-6.8 |
-8.4 |
-6.8 |
Palmitic Acid |
-4.1 |
-4.1 |
-4.3 |
-3.8 |
Phytol |
-4.9 |
-4.9 |
-4.3 |
-4.1 |
Squalene |
-4.8 |
-4.7 |
-4.5 |
-4.2 |
Stearic acid |
-8.9 |
-8.4 |
-8.5 |
-8.1 |
Stigmasterol |
-7.1 |
-6.4 |
-6.7 |
-6.7 |
Figure 4: 3D structures of the dockedphytochemicals derived from Sanchezia oblonga againts Covid protein and Ebola Virus proteins
Figure 5: 2D structures of the docked phytochemicals derived from Sanchezia oblonga against Covid protein and Ebola Virus proteins
UV Visible Spectroscopy:
UV-Vis spectroscopy is an analytical technique that measures the amount of discrete wavelengths of UV or visible light that are absorbed by or transmitted through a sample in comparison to a reference or blank sample. This property is influenced by the sample composition, potentially providing information on what is in the sample and at what concentration. UV spectra ofthe methanol extract ofSanchezia oblonga at 50μg/ml concentration and its UV-VIS spectrum was determined in the wavelength range 200-800 nm a UV- VIS spectrophotometer (Shimadzu 1800) against methanol blank. Here we find a UV-vis peak of 210-280nm which is a characteristic peak of fatty acids as shown in the Figure 6. Our GC-MS analysis is concordant with this observations.
Figure 6. UV spectra of extract derived from Sanchezia oblonga
ADMET (i.e. Absorption, Distribution, Metabolism, Excretion, and Toxicity) profiling of the phytochemicals were performed with the help of pkCSM online server. All the studied compounds have a skin permeability ranging from -2.86 to -1.78. Most of the phytochemicals do not inhibit P-glycoprotein I and II. Blood-brain barrier (BBB) permeability and CNS permeability values are laying between -0.11 to +0.86 and -2.19 to -0.96 respectively. Most of the phytochemicals also do not inhibit CYP2C19, CYP2C9, CYP2D6, CYP3A4, CYP1A2, inhibitors and they do not interact with renal OCT2 substrate. These data are tabulated in Table 5. Here it is very important to note that all the phytochemicals do not show AMES toxicity nor inhibit hERGI inhibitor.
Table 5 : ADMET analysis of UV spectra of extract derived from Sanchezia oblonga
Compound |
Caco2 permeability |
Skin Permeability |
P-glycoprotein substrate |
P-glycoprotein I inhibitor |
P-glycoprotein II inhibitor |
BBB Permeability |
CNS permeability |
CYP2D6 substrate |
CYP3A4 substrate |
CYP1A2 inhibitor |
CYP2C19 inhibitor |
CYP2C9 inhibitor |
CYP2D6 inhibitor |
CYP3A4 inhibitor |
Total Clearance |
Renal OCT2 substrate |
AMES toxicity
|
5methyl4hepten3one |
1.407
|
-1.783
|
No |
No |
No |
0.598
|
-2.192
|
No
|
No |
No |
No |
No |
No |
No |
0.456
|
No |
No |
Campesterol
|
1.223
|
-2.86
|
No |
Yes |
Yes |
0.774
|
-1.758
|
No |
Yes |
No |
No |
No |
No |
No |
0.572
|
No |
No
|
Linoleic acid |
1.57
|
-2.723
|
No |
No |
No |
-0.142
|
-1.6
|
No |
Yes |
Yes |
No |
No |
No |
No |
1.936
|
No |
No |
Oleanolic Acid |
1.17 |
-2.735 |
No |
No |
No |
-0.14
|
-1.157
|
No |
Yes |
No |
No |
No |
No |
No |
-0.081
|
No |
No |
Palmitic Acid |
1.558
|
-2.717
|
No |
No |
No |
-0.111
|
-1.816
|
No |
Yes |
No |
No |
No |
No |
No |
1.763
|
No |
No |
Phytol |
1.515
|
-2.576
|
No |
No |
Yes |
0.806
|
-1.563
|
No |
Yes |
Yes |
No |
No |
No |
No |
1.686
|
No |
No |
Squalene |
1.216
|
-2.768
|
No |
No |
Yes |
0.981
|
-0.955
|
No |
Yes |
No |
No |
No |
No |
No |
1.791
|
No |
No |
Stearic Acid |
1.556
|
-2.726
|
No |
No |
No |
-0.195
|
-1.707
|
No |
Yes |
Yes |
No |
No |
No |
No |
1.832
|
No |
No |
Stigmasterol |
1.213
|
-2.783
|
No |
Yes |
Yes |
0.771
|
-1.652
|
No |
Yes |
No |
No |
No |
No |
No |
0.618
|
No |
No |
The antimicrobial activity of crude extract used against E. coli bacteria as shown in Figure 7. Bio-assay analysis clearly indicates that the methanolic extract derived from Sanchezia oblonga is a source of phytochemicals which possessed antimicrobial activity.
Figure 7: Bio-assay analysis of methanolic extract derived from Sanchezia oblonga
We have also carried out the computational analysis of the phytochemicals derived from the methanolic exact of Sanchezia oblonga plant. The ground state optimized geometries of the phytochemicals are shown in the Figure 8. To find the reactivity parameters we have calculated the HOMO, LUMO energy levels of the phytochemicals and tabulated in the Figure
Figure 8: Ground state geometries of the phytochemicals derived from methanolic extract at B3LYP/6-31+g(d) level of theory
From the above analysis it is clear that stearic acid possesses highest band gap and highest LUMO energy levels which is responsible for showing highest activity against two different targets in the docking analysis as shown Table 6.
Table 6 : HOMO, LUMO energy levels and Bandgap of the phytochemicals derived from methanolic extract derived from Sanchezia oblonga
Name of Compounds |
Homo (eV) |
Lumo (eV) |
Δ(Homo-Lumo) (eV) |
5 methyl 4 hepten 3 one |
-6.61 |
-1.50 |
5.11 |
Campesterol |
-6.42 |
-0.14 |
6.28 |
Linoleic-Acid |
-6.65 |
-0.19 |
6.46 |
Oleanolic-Acid |
-6.22 |
-0.33 |
5.89 |
Palmitic Acid |
-7.86 |
-0.17 |
7.69 |
Phytol |
-6.59 |
-0.36 |
6.23 |
Squalene |
-6.05 |
-0.22 |
5.83 |
Stearic Acid |
-7.85 |
-0.17 |
7.68 |
Stigmasterol |
-6.41 |
-0.18 |
6.23 |
In the present study we have made a systematic analysis of the methanolic leaf extracts of Sanchezia oblonga were used to identify the presence of phytochemicals and investigate the plant's pharmacological properties. TLC analysis indicates the presence of three major components present in the methanolic leaf extracts of Sanchezia oblonga. GC-MS analysis indicates the presence of nine phytochemicals whose antimicrobial activity of crude extract used against E. coli. UV-vis analysis clearly indicates the presence of fatty acids in the extrcat. Additionally, in-silico and DFT analysis clearly indicates that Stearic Acid possesses highest binding afinity against two different targets viz. of two SARS-CoV-2 proteins (PDB ID:6LU7 and PDB ID:6w9c ) and two Ebola virus proteins ( PDB ID:1eS6 PDB ID: 4z9p). This analysis open up new opportunity for the discovery of drugs from the leaf extracts of Sanchezia oblonga.
Financial support
The authors acknowledge no financial support from any funding resources.
Declaration of competing interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
ACKNOWLEDGEMENTS: The authors are grateful to Gour Mahavidyalaya, Malda-732142, India for providing computational resources support in order to continue this research work.
Clinical trial : Not Applicable
Clinical trial No: Not Applicable
Author Contributions Statement
Tanmoy Mazumdar: Drafting of the manuscript, concept, original research
Mainak Banerjee: Supervision, Drafting of the manuscript, concept, original research
Tanmoy Dutta: Drafting of the manuscript, concept
Surajit Saha : Drafting of the manuscript, concept, original research
Swapan Kumar Chowdhury: Supervision, Drafting of the manuscript, concept, original research
REFERENCES
Tanmoy Mazumdar, Mainak Banerjee, Tanmoy Dutta, Surajit Saha, Swapan Kumar Chowdhury, Extraction, Isolation and Characterization of Bioactive Compounds Derived from Sanchezia Oblonga Plant Extract, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 9, 608-624 https://doi.org/10.5281/zenodo.17060288